豐盛服務集團(00331.HK)完成收購香港物業管理服務公司
格隆匯12月16日丨豐盛服務集團(00331.HK)宣佈,有關擬7.05億港元收購香港物業管理服務公司事宜,載於通函內有關建議收購的先決條件已全部達成,根據買賣協議(經補充契據修訂)條款及條件,完成於2019年12月16日落實。於完成後,每一目標實體(合營企業目標實體、國際物業管理有限公司及通力技術服務有限公司除外)成為公司的間接全資附屬公司,目標集團的財務業績、資產及負債將於公司的財務報表綜合入賬。
於完成後,已按發行價每股3.2260港元配發及發行合共4367.64萬股可轉換證券予賣方,以繳足入賬。可轉換證券乃根據於2019年12月6日舉行之股東特別大會授予董事之特別授權配發及發行。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.